COM:BICYCLETHERAPEUTICS

Bicycle Therapeutics

Stock

Last Close

23.60

25/09 14:38

Market Cap

895.71M

Beta: -

Volume Today

72.34K

Avg: -

Overview Analysis Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue		2.06M -	7.14M 246.41%	13.80M 93.40%	10.39M 24.72%	11.70M 12.58%	14.46M 23.65%	26.98M 86.52%
cost of revenue	269.29K -			25.54M -	33.15M 29.79%	44.88M 35.39%	3.69M 91.79%	6.57M 78.24%
gross profit	-269.29K -	2.06M 864.98%	7.14M 246.41%	-11.74M 264.50%	-22.76M 93.88%	-33.18M 45.80%	10.78M 132.48%	20.40M 89.35%
selling and marketing expenses	-325.11K -
general and administrative expenses	3.78M -	6.41M 69.59%	8.12M 26.75%	14.56M 79.29%	29.20M 100.56%	32.44M 11.07%	49.51M 52.63%	59.83M 20.86%
selling general and administrative expenses	3.45M -	6.41M 85.55%	8.12M 26.75%	14.56M 79.29%	29.20M 100.56%	32.44M 11.07%	49.51M 52.63%	59.83M 20.86%
research and development expenses	9.77M -	11.87M 21.44%	20.76M 74.96%	25.54M 23.02%	33.15M 29.79%	44.88M 35.39%	81.61M 81.84%	156.50M 91.76%
other expenses		-119K -	-665K 458.82%	-5.38M 708.57%
cost and expenses	13.49M -	18.27M 35.42%	28.88M 58.06%	40.10M 38.84%	62.35M 55.49%	77.31M 24.00%	131.12M 69.59%	216.33M 64.99%
operating expenses	13.22M -	18.27M 38.18%	28.88M 58.06%	40.10M 38.84%	62.35M 55.49%	77.31M 24.00%	131.12M 69.59%	216.33M 64.99%
interest expense					457K -	2.98M 552.95%	3.34M 12.06%	3.26M 2.42%
ebitda	-13.22M -	-15.88M 20.09%	-21.03M 32.45%	-26.30M 25.03%	-51.28M 94.98%	-65.50M 27.73%	-110.90M 69.31%	-168.80M 52.22%
operating income	-13.49M -	-16.21M 20.15%	-21.75M 34.13%	-26.30M 20.94%	-51.96M 97.57%	-65.62M 26.29%	-116.65M 77.78%	-189.95M 62.83%
depreciation and amortization	269.29K -	332K 23.29%	712K 114.46%	960K 34.83%	683K 28.85%	120K 82.43%	5.76M 4,696.67%	6.55M 13.72%
total other income expenses net	-37.90K -	-119K 214.03%	-665K 458.82%	-4.56M 586.17%	226K 104.95%	-2.86M 1,367.26%	2.41M 184.22%	-594K 124.63%
income before tax	-13.53M -	-16.28M 20.33%	-22.24M 36.60%	-30.86M 38.76%	-51.73M 67.63%	-68.48M 32.37%	-114.24M 66.82%	-179.21M 56.87%
income tax expense	-20.94K -	-23K 9.82%	-396K 1,621.74%	-254K 35.86%	-724K 185.04%	-1.66M 129.70%	-1.52M 8.36%	1.46M 195.60%
net income	-13.51M -	-16.26M 20.34%	-21.85M 34.36%	-30.61M 40.11%	-51.01M 66.66%	-66.82M 30.99%	-112.72M 68.69%	-180.66M 60.28%
weighted average shs out	17.70M -	13.29M 24.88%	13.29M 0%	11.05M 16.91%	19.15M 73.34%	25.06M 30.90%	29.66M 18.35%	35.59M 20.00%
weighted average shs out dil	17.70M -	13.29M 24.88%	13.29M 0%	11.05M 16.91%	19.15M 73.34%	25.06M 30.90%	29.66M 18.35%	35.59M 20.00%
eps	-0.76 -	-1.22 60.53%	-1.64 34.43%	-2.77 68.90%	-2.66 3.97%	-2.67 0.38%	-3.80 42.32%	-5.08 33.68%
epsdiluted	-0.76 -	-1.22 60.53%	-1.64 34.43%	-2.77 68.90%	-2.66 3.97%	-2.67 0.38%	-3.80 42.32%	-5.08 33.68%

All numbers in (except ratios and percentages)